{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:36:40Z","timestamp":1778254600432,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2887,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.fertnstert.2014.04.010","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T08:47:57Z","timestamp":1401353277000},"page":"99-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in\u00a0vitro fertilization cycles"],"prefix":"10.1016","volume":"102","author":[{"given":"David E.","family":"Reichman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Zakarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenny","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen K.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zev","family":"Rosenwaks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2014.04.010_bib1","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","volume":"15","author":"Borm","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.04.010_bib2","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/humrep\/15.9.1965","volume":"15","author":"Itskovitz-Eldor","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.04.010_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/PL00007479","article-title":"Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction","volume":"264","author":"Ludwig","year":"2000","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2014.04.010_bib4","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/humrep\/13.11.3023","volume":"13","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.04.010_bib5","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/humrep\/deh334","article-title":"The effect of an individualized GnRH antagonist protocol on folliculogenesis in IVF\/ICSI","volume":"19","author":"Mochtar","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.04.010_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1472-6483(10)61661-6","article-title":"Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol","volume":"10","author":"Al-Inany","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2014.04.010_bib7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2010.05.052","article-title":"Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in\u00a0vitro fertilization: a randomized controlled trial","volume":"95","author":"Kolibianakis","year":"2011","journal-title":"Fertil Steril"},{"issue":"Suppl 6","key":"10.1016\/j.fertnstert.2014.04.010_bib8","first-page":"A92","article-title":"An international multicenter reference range study of normal menstrual cycles using IMMULITE reproductive hormone assays","volume":"45","author":"Vanrkrieken","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.fertnstert.2014.04.010_bib9","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.fertnstert.2012.11.044","article-title":"Consecutive gonadotropin-releasing hormone-antagonist in\u00a0vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?","volume":"99","author":"Reichman","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.04.010_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.fertnstert.2011.06.042","article-title":"Is a premature rise in luteinizing hormone in the absence of increased progesterone levels detrimental to pregnancy outcome in GnRH antagonist in\u00a0vitro fertilization cycles","volume":"96","author":"Dovey","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.04.010_bib11","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.fertnstert.2010.12.046","article-title":"In\u00a0vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle","volume":"95","author":"Kummer","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.04.010_bib12","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.fertnstert.2009.12.055","article-title":"Failure of the GnRH antagonist ganirelix to block the positive feedback effect of exogenous estrogen in normal women","volume":"94","author":"Messinis","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.04.010_bib13","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/humrep\/deh383","article-title":"Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role","volume":"19","author":"Dafopoulos","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.04.010_bib14","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/humrep\/17.3.634","article-title":"Women with poor response to IVF have lowered circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spontaneous and stimulated cycles","volume":"17","author":"Martinez","year":"2002","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214003550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214003550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:11:41Z","timestamp":1758010301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028214003550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0015028214003550"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.04.010","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in\u00a0vitro fertilization cycles","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}